478 filings
SC 13D/A
Meyer Thomas
13 Mar 24
Altamira Therapeutics / Meyer Thomas ownership change
11:03am
424B4
CYTO
Altamira Therapeutics Ltd
22 Jan 24
Prospectus supplement with pricing info
5:02pm
EFFECT
CYTO
Altamira Therapeutics Ltd
22 Jan 24
Notice of effectiveness
12:15am
6-K
CYTO
Altamira Therapeutics Ltd
19 Jan 24
Report of Foreign Private Issuer
4:45pm
424B5
CYTO
Altamira Therapeutics Ltd
19 Jan 24
Prospectus supplement for primary offering
4:40pm
6-K
tfkyc0sm qm9kh
19 Jan 24
Report of Foreign Private Issuer
4:30pm
CORRESP
cp2vi
17 Jan 24
Correspondence with SEC
12:00am
UPLOAD
297yq q5wrvzl7sppd7
16 Jan 24
Letter from SEC
12:00am
F-3
xg5fh2
8 Jan 24
Shelf registration (foreign)
5:02pm
6-K
fz1xd8cxprlh
11 Dec 23
Altamira Therapeutics Provides Investor and Business Update
8:01am
6-K
7yh6h0g08
11 Dec 23
Report of Foreign Private Issuer
8:00am
6-K
fm1t21r pkc9n
8 Dec 23
Report of Foreign Private Issuer
9:00am
6-K
j5von2z0fia596i0
22 Nov 23
Report of Foreign Private Issuer
4:30pm
6-K
6a22 uatnh68
21 Nov 23
Report of Foreign Private Issuer
8:00am
6-K
ckq1vagejoq yf1o0v
31 Oct 23
Report of Foreign Private Issuer
4:30pm
6-K
x8f8yrh0ax40nsm6x3f
4 Oct 23
Notice of the Special General Meeting of Shareholders
9:00am
6-K
nxdof7o00
12 Sep 23
Report of Foreign Private Issuer
7:30am
6-K/A
6o9lovq619z s0lldc0
21 Aug 23
Current report (foreign) (amended)
7:31am
6-K
tquehlivd xtby9h0jh
28 Jul 23
Current Report
7:00am
6-K
1yx8bpd et0pmhdzq
26 Jul 23
Report of Foreign Private Issuer
9:00am